Scienture Holdings, Inc. (Nasdaq: SCNX) has entered into a securities purchase agreement with institutional investors for the purchase of 3,225,000 shares of common stock at $1.20 per share in a registered direct offering.
The gross proceeds for the offering are expected to be approximately $3.9 million before expenses.
The offering is expected to close on August 15, 2025, subject to customary closing conditions.
Offering Details
3,225,000 shares of common stock at $1.20 per share, expecting gross proceeds of $3.9 million.
Placement Agent
Maxim Group LLC is acting as the sole placement agent for the offering.
Regulatory Compliance
The offering is made under an effective shelf registration statement on Form S-3, filed with the SEC on August 1, 2025.
- The registered direct offering will provide Scienture Holdings with substantial funding for its operations and product development.
- Maxim Group LLC's involvement as the placement agent adds credibility to the offering and enhances investor confidence.
With the successful completion of this offering, Scienture Holdings, Inc. is poised to strengthen its financial position and accelerate the development of novel specialty products.